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1. Introduction 
Protein kinases constitute one of the largest and best-explored superfamilies of mammalian 
genes. The human genome encodes approximately 518 protein kinase genes, and the 
majority of their proteins have been characterized to some extent. Many of protein kinases 
have been implicated in signal transduction pathways that regulate growth and survival of 
cells, indicating their potential role in cancer (Manning et al., 2002a). Indeed, most cancers 
are associated with disregulation of protein kinases or by loss or damage of cellular protein 
kinase inhibitors (Brognard & Hunter, 2011; Johnson, 2009; Pearson & Fabbro, 2004).  
A typical protein kinase (based on 478 known enzymes) is characterized by the presence of a 
highly homologous kinase catalytic domain of about 300 amino acid residues. This domain 
serves three distinct roles: (a) binding and orientation of the phosphate donor (ATP or, 
rarely, a different nucleoside triphosphate) in a complex with a divalent cation (usually 
Mg2+ or Mn2+); (b) binding and orientation of the protein substrate; and (c) transfer of the γ-
phosphate from the NTP to the hydroxyl moiety of the acceptor residue of the protein 
substrate. 
In response to a variety of regulatory signals, protein kinases phosphorylate specific serine, 
threonine, or tyrosine residues within target proteins to modify their biological activities. 
Phosphorylation of several proteins in the cell creates recognition and/or regulatory sites 
that influence many properties of the target proteins (e.g., catalytic activity, localization, 
sensitivity to proteolytic degradation, protein-protein interaction, etc). In eukaryotes, 
Ser/Thr and Tyr protein kinases (Note: The single- and three-letter codes for the amino 
acids are given in Table 1 in the chapter by Figurski et al.) play a key role in molecular 
networks controlling the activity of various signaling proteins (Brognard & Hunter, 2011; 
Cohen, 2002). Ser/Thr and Tyr-protein kinases form the largest protein family in the human 
genome (Pandit et al., 2004). They constitute about 2-3% of the proteomes of other model 
organisms, such as Saccharomyces cerevisiae, Caenorhabditis elegans and Drosophila melanogaster 
(Manning et al., 2002 a, b; Goldberg et al., 2006; Plowman et al., 1999). Based on the 
conserved features of catalytic domains of eukaryotic protein kinases, Hanks and coworkers 
have placed the kinases into various classes, groups, and subfamilies (Hanks et al., 1988). 
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The first 3D structure of a protein kinase was determined for PKA by X-ray crystallography. 
It revealed the basic bi-lobed scaffold formed by N- and C-terminal lobes that has been 
observed in all the protein kinase structures solved to date. The N-terminal lobe of the 
kinase fold comprises of an anti-parallel β-sheet made of five β-strands (β1 – β5) and a 
single αC-helix. The C-terminal lobe is larger and is mainly composed of α-helices. The 
nucleotide- and substrate-binding pockets are located in the cleft between the two lobes. The 
phosphate groups of ATP are positioned for phosphotransfer by their interactions with 
conserved residues in the N- and C-terminal lobes. These include a glycine-rich loop 
characterized by the GXGXXG motif (where X represents any amino acid) between the β1 
and β2 strands, a Lys residue localized by a salt bridge formed by a Lys-Glu pair (K72 and 
E91), and Mg2+ ions. The conserved Asn (N171) and Asp (D184) further coordinate the metal 
ions. The catalytic loop situated in the C-terminal lobe contains aspartate (D166), referred to 
as the catalytic base that facilitates extraction of a proton from the hydroxyl side-chains of 
the phospho-sites of the substrates. The activation segment (20–30 residues in length) caps 
the C-terminal lobe. This segment forms a part of the substrate-binding pocket and shows 
high structural variation in the active and inactive kinase structures. 
The grouping of the protein kinases based on catalytic subunit sequence similarity results in 
clustering of kinases that share functional features, such as preferred sites of 
phosphorylation, the mode of regulation and cellular localization. The similarity in the 
amino acid sequence of the catalytic domains of protein kinases has proven to be a good 
indicator of other features held in common by the different members of the family. 
The diversity of essential functions mediated by kinases is shown by the conservation of 
approximately 50 distinct kinase families that have been identified in yeast, invertebrates, 
and mammals. Protein kinases can be clustered into groups, families, and sub-families. 
These classifications are based on sequence similarity and biochemical function. Among the 
518 human protein kinases, 478 belong to a single superfamily whose catalytic domains are 
related in sequence.  
Protein kinases are divided into 10 main groups, which organize diversity and compare 
genes between distant organisms (Miranda-Saavedra & Barton, 2007). The groups are 
named as follows: AGC, CAMK, CK1, CMGC, STE, RGC, Other, TK, TK, and Atypical. This 
classification was first used for characterization of the human kinome (all the kinases 
encoded in the genome) (Manning et al., 2002) and is based on an earlier classification by 
Hanks and Hunter (1995). 
1.1 The CMGC kinases 
This group of Ser/Thr protein kinases was named after the initials of some members (CDK, 
MAPK, GSK3, and CLK). It includes key kinases involved in growth, stress-response, and 
the cell cycle, and kinases involved in splicing and metabolic control. The four well 
characterized subfamilies of this group include the following: cyclin-dependent kinases 
(CDK) (Liolli, 2010); mitogen-activated protein kinases (MAPK) (Biondi & Nebreda, 2003; 
Zhang & Dong, 2007); glycogen synthase kinases (GSK) (Biondi & Nebreda, 2003); and cell 
kinases 2 (CK2), better known as protein kinase CK2 or casein kinase 2 (St-Denis & 
Litchfield, 2009). The CMGC group also contains other members. These are the following: 
SR protein kinases [phosphorylating serine- and arginine-rich proteins engaged in 
regulation of splicing and nuclear transport (Ghosh & Adams, 2011)] and DYRK protein 
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kinases, i.e. dual-specificity tyrosine-phosphorylated protein kinases, presumably involved 
in brain development (Becker et al., 1998). 
1.2 Protein kinase CK2 
Protein kinase CK2, formerly called casein kinase II, is a ubiquitous second messenger-
independent protein kinase found in all eukaryotic organisms examined (Jensen et al., 2007; 
Niefind et al., 2009; Litchfield, 2003, Kubiński et al., 2007). This enzyme, which has been 
studied for over 50 years, is able to phosphorylate more than 300 substrates, on serine, 
threonine and tyrosine (Meggio & Pinna, 2003; Vilk et al., 2008). As the list of targets for CK2 
continues to grow, it is becoming evident that CK2 has the potential to participate in the 
regulation of various cellular processes. Most of the CK2 substrates reported so far correspond 
to proteins that participate in cell signaling (Ahmed et al., 2002; Meggio & Pinna, 2003). 
 
Fig. 1. Model structures of the CK2α and CK2β subunits from Mytilus galloprovincialis 
(Mediterranean mussel) (Koyanou-Koutsokou et al., 2011b) 
The structural features of the CK2α and CK2β subunits were elaborated using the SWISS-MODEL 
Workspace for protein structure homology modeling (Arnold et al., 2006; Kopp and 
Schwede 2004) and 1ds5D (Batistuta et al., 2000) or 3EED (Raaf et al., 2008) as templates, 
respectively. 
Protein kinase CK2 is distributed ubiquitously in eukaryotic organisms, where it appears as 
a tetrameric complex composed of two catalytic subunits (α/α’) associated with a dimer of 
regulatory β subunits (Figs. 1 & 2). The CK2 tetramer exhibits constitutive activity that can 
be easily detected in most cellular or tissue extracts in the absence of any stimulatory 
compounds. In many organisms, distinct isoenzymic forms of the catalytic subunit of CK2 
have been identified (Glover, 1998; Kolaiti et al., 2011; Kouyanou-Koutsoukou et al., 2011a, 
b; Maridor et al., 1991; Litchfield et al., 1990; Shi et al., 2001). In humans, only a single 
regulatory CK2β subunit has been identified; but multiple forms of CK2β have been 
identified in other organisms, such as Saccharomyces cerevisiae (Glover, 1998). 
Complementary evidence indicates that dimers of CK2β are at the core of the tetrameric 
CK2 complexes (Graham & Litchfield, 2000; Pinna & Meggio, 1997). Tetrameric CK2 
complexes may contain identical (i.e., α2β2 or α’2β2) or non-identical (i.e., αα’β2) catalytic 
subunits (Gietz et al., 1995). Holoenzyme composition may influence CK2 properties, 
namely nucleotide and protein substrate specificity and sensitivity to effectors (Janeczko et 
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al., 2011). Protein kinase CK2 holoenzyme and its catalytic subunit alone can use both ATP 
and GTP as phosphate donors (Issinger, 1993).  
The catalytic subunits of CK2α and CK2α’ are the products of separate genes located in 
different chromosomes. The 330 N-terminal amino acids exhibit over 90% sequence identity. 
However, the C-terminal sequences are unrelated (Olsten & Litchfield, 2004). The unique C-
terminal domains of the catalytic subunits are highly conserved among species (e.g., the 
amino acid sequences of the C-termini of the catalytic subunits of human and chicken CK2α 
and CK2α’ exhibit 98% and 97% identity, respectively), indicating a possible functional 
importance for this domain (Litchfield, 2003). 
Although there is no known difference between the catalytic activities of CK2α and CK2α’, 
there is evidence that they exhibit functional specialization (Duncan & Lichfield, 2008; Faust 
& Montenarch, 2000). The CK2α subunit is phosphorylated at C-terminal sites (Thr344, 
Thr360, Ser362 and Ser360) by p34cdc2 during cell cycle progression, while CK2α’ is not 
phosphorylated (St-Denis et al., 2009). Further evidence to support the idea that CK2α and 
CK2α’ have independent functions in the cell is provided by the different specificities of 
cellular binding proteins, such as CKIP-1, Hsp90, Pin-1, and PP2A (Olsten et al., 2005). 
Despite the many isoforms of catalytic subunits, only one regulatory subunit has been 
identified for CK2β in mammals (Allende and Allende, 1995). In contrast to the activity of 
regulatory subunits of other kinases, such as PKA (cAMP-dependent protein kinase) and 
CDK (cyclin-dependent protein kinase), CK2β does not switch on or off the intrinsic activity 
of the catalytic subunits (Bolanos-Garcia et al., 2006). 
The CK2β regulatory subunit is remarkably conserved among species, but it does not have 
homology with the regulatory subunits of other protein kinases (Bibby & Litchfield, 2005). 
The amino acid sequence of the CK2β regulatory subunit is almost identical in Homo sapiens, 
Drosophila melanogaster, Ceratitis capitata (Mediterranean fruit fly), Danio rerio (zebrafish), 
Ciona intestinalis (sea squirt), and Mytilus galloprovincialis (Mediterranean mussel) 
(Kouyanou-Koutsoukou et al., 2011a, b; Kolaiti et al., 2011). It is completely identical in birds 
and mammals (Maridor et al., 1991; Wirkner et al., 1994). In contrast, the fruit fly D. 
melanogaster has four regulatory subunit genes. They are used for one CK2α (DmCK2α) and 
three CK2βs (DmCK2β, DmCK2β' and DmCK2βtes) (Jauch et al., 2002). Zea mays has three 
isoforms of the catalytic α-subunit (CK2a-1, CK2a-2 and CK2a-3) and three regulatory β-
subunits (CK2b-1, CK2b-2 and CK2b-3) (Riera et al., 2001). S. cerevisiae CK2 holoenzyme 
contains two regulatory β-subunits (β and β’). They cannot substitute for each other, and 
both of them are needed to form a fully active enzymatic unit (Kubinski et al., 2007).  
Results presented by several groups and obtained by the use of a variety of approaches, 
including X-ray crystallography, have determined that a dimer of the CK2β subunits forms 
the core of the CK2 tetramer (Chantalat et al., 1999; Sarno et al., 2000; Canton et al., 2001). 
The CK2β regulatory subunit is a compact, globular homodimer that shows high amino acid 
sequence conservation across species. The N-terminal domain (amino acids 1-104) is 
globular and contains four α-helices (marked as α1-α4 in Fig. 1). Helices α1 (residues 9–14), 
α2 (residues 27–31) and α3 (residues 46–54) wrap around α4 (residues 66–89) (Bolanos-
Garcia et al., 2006). This part of the protein contains autophosphorylation sites, consisting of 
serines 2, 3, and possibly 4 (Boldyreff et al., 1993). Studies conducted by Zhang and 
coworkers (2002) indicate that phosphorylation of these sites enhances CK2β stability. The 
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first 20 N-terminal amino acids of the CK2β regulatory subunit are also involved in the 
interaction with Nopp140, a protein that binds a nuclear localization sequence and shuttles 
between the nucleus and the cytoplasm (Li et al., 1997). This part of the protein also contains 
two motifs that have been previously characterized as motifs that regulate cyclin 
degradation. The CK2β regulatory subunit has a sequence resembling the nine-amino-acid 
motif called the destruction box, which plays a key role in the specific degradation of cyclin 
B at the end of mitosis (King et al., 1996). This motif, located in helix α3, contains three 
highly conserved residues that conform to the general destruction box consensus 
(RXXLXXXXN/D) (Bolanos-Garcia et al., 2006). Interestingly, this motif is located on a 
surface-exposed α3 helix, where it would be available for recognition by the cellular 
degradation machinery. A signal known as the KEN box, which was found previously in 
mitotic cyclins and which has been shown to play a role in mediating cell cycle-dependent 
protein degradation, is also present in CK2β. This degradation motif is characterized by the 
minimal consensus sequence KEN, but it is often followed shortly by either an N or D 
residue and is often preceded by another N or D residue. A similar sequence 
(D32KFNLTGLN40) forms helix α2 of the CK2β protein (Bibby & Litchfield, 2005). 
The N-terminal part of the CK2β also contains an “acidic loop” between helices α3 and α4. 
This acidic, surface-exposed region of the protein, encoded by residues 55-64, has been 
identified as the site on CK2 that binds polyamines, which are known to stimulate CK2 
activity in vitro (Meggio et al., 1994; Leroy et al., 1997). 
The analysis of the CK2β regulatory subunit structure by X-ray crystallography revealed the 
importance of the zinc finger in CK2β regulatory subunit dimerization (Chantal et al., 1999). 
The zinc-finger region is characterized by four conserved cysteine residues (residues 109, 
114, 137 and 140), which mediate the interaction that allows the CK2β dimer to form the core 
of the CK2 holoenzyme (Chantal et al., 1999; Canton et al., 2001). 
The C-terminal part of the CK2β regulatory subunit  (residues 178–205) contains a large loop 
(residues 178–193) and helix α7 (residues 194–200). Although helix α7 is located away from 
helices α1-α6, the C-terminal amino acids (190-205) contribute to the formation of the CK2β 
regulatory subunit dimer (Niefind et al., 2001). This part of the regulatory subunit contains 
two phosphorylation sites: Thr213, which is phosphorylated by the checkpoint kinase Chk1 
(Kristensen et al., 2004) and Ser209, which is phosphorylated in vitro and in mammalian cells 
by p34cdc2 in a cell-cycle-dependent manner (Litchfield et al., 1995). 
The traditional view of the CK2β regulatory subunit is that it functions as a component of 
tetrameric CK2 complexes and that it is the regulator of the catalytic CK2α and CK2α’ 
subunits, enhancing their stability, specificity and activity. As an example, the CK2β 
regulatory subunit stimulates CK2 holoenzyme activity towards certain protein substrates, 
such as topoisomerase II (Leroy et al., 1999), and inhibits others, like calmodulin (Marin et 
al., 1999).  
It was shown that CK2β does not exist exclusively within stable CK2 complexes. This 
observation raises the prospect that CK2β has functions that are independent of its role as 
the regulatory subunit of CK2. For example, overexpression of CK2β in the fission yeast 
Schizosaccharomyces pombe revealed severe growth defects and a multiseptated phenotype, 
whereas CK2α overexpression had no effect (Roussou & Draetta, 1994).  
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CK2β seems to interact directly with more than 40 different proteins, including other protein 
kinases such as A-Raf, Chk1, Chk2, PKC-ζ, Mos and p90rsk (Bibby & Lichfield, 2005; Bolanos-
Garcia et al., 2006; Olsen & Guerra, 2008). It was shown that association of the human 
protein kinases Chk1, Mos, and A-Raf is mediated by the C-terminal region of the CK2β 
subunit and that these associations involve some residues that interact with the catalytic 
CK2α subunit (Chen et al., 1997; Lieberman & Ruderman, 2004; Olsen & Guerra, 2008). The 
interaction between Chk1 and CK2β leads to an increase in the Cdc25C phosphorylation 
activity of Chk1. Screening of several cell lines has shown that the association between CK2β 
and Chk1 is also formed in vivo (Guerra at al., 2003). 
Overexpression of CK2 has been linked to several pathological conditions, ranging from 
cardiovascular pathologies and cancer progression to neurodegenerative disorders (e.g., 
Alzheimer’s disease, Parkinson’s disease, brain ischemia) and infectious diseases (Guerra & 
Issinger, 2008; Ahmad et al., 2008; Trembley et al., 2009). Various specific, potent small 
molecule inhibitors of protein kinase CK2 have been developed in recent years, including 
condensed polyphenolic compounds, tetrabromobenzimidazole/triazole derivatives, and 
indoloquinazolines (Gianoncelli et al., 2009; Pagano et al., 2008; Raaf et al., 2008). Inhibition 
of CK2 kinase activity by these compounds display a remarkable pro-apoptotic efficacy on a 
number of tumor-derived cell lines, indicating a possibility of developing novel 
antineoplastic drugs (Batistuta, 2009; Duncan et al., 2010; Prudent et al., 2010; Unger et al., 
2004). 
2. Mutagenesis in studies on protein kinase CK2 
Within the last 2 decades, a number of studies have produced mutants of both CK2α and 
CK2β that provide a valuable, yet incomplete, basis to rationalize the biochemical features of 
the enzyme, i.e., its constitutive activity, dual-cosubstrate specificity, acidophilic substrate 
specificity and tetrameric structure (Fig. 2). 
2.1 Mutagenesis of the CK2α catalytic subunit  
2.1.1 Mutations of CK2α in the regions responsible for constitutive activity 
A majority of protein kinases need to be activated. Phosphorylation within the kinase 
activation loop is the most popular mode of activation. In contrast to other known protein 
kinases, CK2 has constitutive activity and does not demand activation. In this case, 
activation is achieved by the interaction between the N-terminal tail and the activation loop 
in the kinase domain. The role of the N-terminal segment in stable opening of the activation 
loop was confirmed in mutagenesis studies (Sarno et al., 2001). In particular, the Δ2-12 CK2α 
mutant, in comparison with the wild-type kinase, displayed an almost complete loss of 
activity, which was reflected by increased Km values for ATP and the peptide substrate 
(from 10 to 206 µM and from 26 to 140 µM, respectively). Further experiments revealed that 
holoenzyme reconstitution restored the activity of the mutant to the wild-type level. This 
demonstrates an alternative CK2β subunit-dependent mechanism to provide constitutive 
activity in the case of CK2 holoenzyme (Sarno et al., 2002). 
Recently, molecular dynamics (MD) simulation has been carried out in order to explore the 
role of the CK2α N-terminal segment in the conformational behavior of the kinase (Cristiani 
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Fig. 2. Multiple applications of mutagenesis in studies on CK2. 
The blue box presents various aspects of research using mutagenesis on CK2α; and the 
yellow box, on CK2β. The model of the human CK2 holoenzyme was developed using the 
PyMOL software based on the structure of the human CK2 holoenzyme (PDB code 1JWH) 
from the Protein Data Bank. The catalytic α subunits are presented in blue and green; the 
regulatory β subunits are in red and yellow. 
et al., 2011). Comparison of the αC-helix RMSD (root mean square deviation) values 
obtained for the Δ2-12 CK2α mutant (i.e., deleted for residues 2 through 12) and the wild-
type kinase models show an increase in this parameter for the mutant form of the enzyme. 
This effect is due to instability of the CK2α conformation in the case of absence of an N-
terminal segment and its interaction with the αC-helix. These results are consistent with the 
data presented by Sarno and collaborators, and they indicate that the complete N-terminal 
segment is essential for proper conformation and constitutive activity of protein kinase 
CK2α (Cristiani et al., 2011). 
The experiment presented above is an example of the validation of in vitro mutagenesis 
studies with the use of computing analysis, but the opposite direction of studies is also 
possible. Two CK2α mutants, the triple mutant Y206F/R10A/Y261F and the single mutant 
Y125F, were constructed in silico. MD simulations were then carried out to study the relation 
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between CK2 conformation and activity (Cristiani et al., 2011). The amino acids substituted 
in the first virtual mutant are engaged in the most important bonds between the N-terminal 
segment and other regions of CK2α to maintain kinase activity. The CK2α Y125F mutant is 
also very useful in studying the influence of Tyr125 on the conformational change of Phe121. 
According to Niefind and Issinger (2010), Phe121 can assume two different conformations: 
in and out, which regulate the activity of CK2α. Preliminary MD simulations on the two 
protein mutant models are very promising. The authors are currently working on the 
construction of both CK2 mutants. Biochemical characterization of the mutants will be 
carried out (Cristiani et al., 2011). 
2.1.2 Mutation of CK2α in the basic regions  
Protein kinase CK2 is characterized by its special aptitude to interact with negatively 
charged ligands. This ability correlates with the presence of several basic residues in CK2α 
that are not conserved in a majority of other protein kinases. These residues are located 
mainly in the “Lys-rich segment” and in the “p+1 loop.” The Lys-rich segment 
(K74KKKIKR80) at the beginning of the αC-helix is a distinctive feature of CK2α (Tuazon & 
Traugh, 1991; Guerra et al., 1999). Results from mutational studies support the notion that 
this cluster is involved in substrate recognition, inhibition by heparin, down-regulation by 
the CK2β subunit and interaction with heat shock protein 90, and nuclear targeting (Guerra 
et al., 1999; Pinna & Meggio, 1997) (Table 1). CK2α mutants from Caenorhabditis elegans and 
Xenopus laevis (K74E/K75E and K75E/K76E, respectively) had lysines replaced by glutamic 
acid residues, which greatly affected the charge of this region in both mutant enzymes. The 
changes produced neither a significant increase in the Km of the CK2α subunit for the casein 
and model peptide substrates nor changes in the affinity of the mutated CK2α subunit for 
the CK2β subunit during assembling a fully competent CK2 holoenzyme. The same 
mutations, however, had a significant effect on the affinity of CK2α for heparin and for 
other polyanionic inhibitors (Hu & Rubin, 1990; Gatica at al., 1994). Complete suppression of 
heparin inhibition was observed with the quadruple mutated K74-77A CK2α used by Vaglio 
and collaborators (1996). These authors showed (1) that all the four basic residues at 
positions 74, 75, 76, and 77 are implicated in heparin binding and (2) that the mutation of all 
of them was necessary to minimize heparin inhibition. Further mutagenesis studies showed 
that the additional basic residues cooperated with high heparin binding (apart from the 74-
77 quartet). These were mainly Arg191, Arg195 and Lys198 located in the p+1 loop. 
However, the triple mutant for the three non-Lys-rich segment residues was less effective in 
heparin inhibition than was the mutant resulting from quadruple mutation of the 74-77 
cluster (Vaglio et al., 1996). The triple mutant in which Lys79, Arg80 and Arg83 were 
changed into alanines did not alter the IC50 (concentration needed to give 50% inhibition) 
value for heparin. However, the mutant did show a reduction in the phosphorylation 
efficiency of the peptide substrate (and derivatives in which individual aspartyl residues 
were replaced by alanines). Because of these properties, it was specified that the basic 
residues in positions 77-83 are mainly involved in substrate recognition, rather than in 
heparin inhibition (Sarno et al., 1995; Vaglio et al., 1996). These authors concluded that the 
highly conserved 74-80 basic stretch is composed of two functionally distinct entities: (1) an 
N-terminal moiety mostly involved in heparin inhibition as well as in down-regulation by 
the β subunit and (2) the C-terminal part implicated in recognition of the crucial specificity 
determinant at positions n+3, but irrelevant to heparin. 
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Extended mutagenesis analysis combined with biochemical characterization provided clear 
evidence that residues responsible for both substrate recognition and down-regulation of 
CK2α catalytic activity are located mainly in the Lys-rich loop and p+1 loop spanning 
sequences 74-83 and 191-198, respectively. This corroborates the concept that the CK2β 
subunit down-regulates the CK2β by acting as a pseudosubstrate (Meggio et al., 1994; Sarno 
et al., 1996, 1997a, 1999).  
Sarno and collaborators (1997b) analyzed the relative contribution of basic residues, 
presumably implicated in CK2-substrate interaction, in the recognition of peptide substrates 
varying in the number and position of acidic determinants. Sixteen derivatives of the optimal 
peptide substrate RRRA-DDSDDDDD, wild-type CK2 and twelve CK2α mutants defective in 
substrate recognition were used in the experiments. In the CK2α mutants, different basic 
residues implicated in substrate recognition were replaced by alanine (e.g.,  K49A, K74-77A, or 
K79A/R80A/K83A). The results obtained support the idea that the acidic residues at positions 
n+1 and n+3 are essential, while additional acidic residues are required for efficient 
phosphorylation of CK2 substrates. Kinetic analysis with CK2α mutants revealed that Lys48 
was implicated in the recognition of the determinant at position n+2. Lys77 interacts with the 
determinants at n+3 and n+4, while Lys198 recognized the determinant at n+1 (Sarno et al., 
1997b). Molecular modeling based on crystallographic data supported these observations. It 
showed that several of these basic residues are clustered around the active site, where they 
make contact with individual acidic residues of the peptide substrate, polyanionic inhibitors, 
regulatory elements present in the β subunit, N-terminal segment of the CK2α, and possibly 
other proteins interacting with CK2 (Sarno et al., 1999). 
2.1.3 Mutations of CK2α in catalytic subdomains 
Subdomains II and VII of CK2α involved in nucleotide binding and phosphotransfer are in 
close proximity to each other in the three-dimensional structure.  CK2α differs from more 
than 95% of other known protein kinases in having Val66 instead of the corresponding 
alanine within conserved region II and Trp176 instead of the corresponding phenylalanine 
within region VII (Allende & Allende, 1995). To investigate whether these variant amino 
acid residues might be responsible for effective GTP utilization, Jakobi and Traugh (1995) 
mutated both of these residues back to the consensus amino acids. Their results indicated 
that both single mutants of CK2α and the double mutant CK2α could still use GTP as a 
phosphate donor. The single and double mutations only altered the relative affinities for 
ATP and GTP. This finding indicated that at least one other amino acid residue must be 
responsible for the effective utilization of GTP by CK2. The same authors studied the above-
mentioned mutants with respect to the catalytic activity of the reconstructed holoenzyme. 
The relatively lower affinity for GTP of the holenzyme reconstructed from the mutated 
CK2α was caused by changes in both the Km and Vmax values for GTP and ATP, while for the 
catalytic subunits, it was a result of changes in the Km values only. These studies showed 
that the unique property of the effective utilization of GTP by CK2 was correlated with 
stimulation of the activity by the regulatory subunits and with the ability to undergo a 
conformational change upon formation of the holoenzyme. 
Srinivasan and collaborators (1999) showed that the dual specificity of CK2 probably 
originated from the loop situated around the stretch H115VNNTD120 in CKα. In their work, 
they combined site-directed mutagenesis of CK2α with comparative 3D-structure modeling. 
 
Genetic Manipulation of DNA and Protein – Examples from Current Research 142 
Due to significant amino acid sequence similarity (69,5%), kinase CDK2 was chosen to be a 
good comparative model for CK2α. Based on modeling, a ΔN118 CK2α mutant was 
constructed. The kinase assay showed decreased affinity of this protein to GTP, in comparison 
to the wild-type CK2α. The Km values were 146 and 37 µM, respectively. The results obtained 
clearly indicate that the adenine/guanine binding region (His115–Asp120) is responsible for 
the dual specificity of kinase towards phosphate donors (Srinivasan et al., 1999). 
The latter study was extended by Jakob and collaborators (2000), who created several 
mutants of Xenopus laevis CK2α with substitutions at positions 118 and 129.  They tested 
them for cosubstrate specificity after their combination with CK2β. The region containing 
Asn118, known to participate in the recognition of the guanine base, is a part of the 
sequence N117NTD120.  This sequence closely resembles the conserved sequence NKXD that 
is present in G proteins and other GTPases. The study demonstrated that both the CK2α 
ΔN118 and CK2α N118E mutants produced a 5 to 6-fold increase in the Km for GTP with 
little effect on the affinity for ATP. 
The mutagenesis  by Yde and collaborators (2005) resulted in the first stable and fully active 
mutant of the human catalytic subunit of protein kinase CK2 that is devoid of dual 
cosubstrate specificity. The resulting mutant hsCK2α1-335 (human CK2 deleted for the last 
56 amino acids) V66A/M163L was designed on the basis of several structures of the enzyme 
from Zea mays in a complex with various ATP-competitive ligands. As structural research 
revealed the existence of a purine base-binding plane harboring the purine base of ATP and 
GTP. This plane is flanked in human CK2α by two side-chains of Val66 and Met163, and it 
adopts a significantly different orientation than it does in other kinase homologues. By 
exchanging these two flanking amino acids, the cosubstrate specificity is shifted towards 
strongly favoring ATP. These findings demonstrated that CK2α possesses a sophisticated 
structural adaptation that favors dual-cosubstrate specificity, a property that may have 
biological significance. 
The mutagenesis studies also provided much insight into the significance of the sequence of 
the catalytic domain with respect to the CK2α/CK2β interaction. It was reported that  CK2α 
V66A and  V66A/W176F were able to interact with CK2β, but this interaction failed to 
stimulate catalytic activity on the peptide substrate.  These results were in contrast to the 
result with the wild-type α subunit, which was stimulated 4-fold. Nevertheless, the 
stimulatory response to the cationic modulatory compounds, spermine and polylysine, was 
the same for holoenzymes reconstituted with the wild-type subunit and all three above-
mentioned mutants of the α subunit. The results showed that there must be at least two 
different interactions between the catalytic α and regulatory β subunit: one that is 
responsible for stimulation by the β subunit itself and another for mediating the stimulation 
by polycationic compounds (Jakobi & Traugh, 1992). However, experiments using 
calmodulin as a substrate for phosphorylation revealed that the insensitivity of the CK2α 
mutant V66A to CK2β was only apparent. Down-regulation of calmodulin phosphorylation 
by the CK2β subunit is even enhanced by the V66A mutant.  This observation indicated a 
possible indirect role for Val66 in conferring to the α-subunit a conformation less sensitive to 
down-regulation (Sarno et al. 1997a). 
It is known that the hydrophobic and polar residues of domain II and VII are responsible for 
the selectivity of a number of specific, potent CK2 ATP-competitive inhibitors, like TBBz  
 
Site-Directed Mutagenesis in the Research of Protein Kinases - The Case of Protein Kinase CK2 143 
(tetrabromobenzimidazole) and TBBt (tetrabromobenzotriazole) (Sarno et al., 2005a). The 
importance of the same key residues in the hydrophobic portion of the binding site was 
corroborated by mutational analysis of residues of the human CK2α. Their side chains 
contribute to the reduction in the internal size of the hydrophobic pocket adjacent to the 
ATP/GTP-binding site in CK2 (Battistutta et al., 2001; Sarno et al, 2005). Three of these 
residues (Val66 or Ile66, Ile174, and Met163) are specific to CK2. They are generally replaced 
by smaller ones in other protein kinases. Both single and double mutants with substitutions 
for Val66 and Ile174 gave rise to catalytically active CK2α with altered susceptibility to 
various inhibitors. However, replacement of Met163 by glycine produced a catalytically 
inactive mutant (Sarno et al., 2005b). Similar data were obtained with yeast CK2α. Mutants 
with alterations to V67 and I213 (analogous to V66 and I174 of human CK2α) displayed 
considerably higher Ki values toward inhibitors TBBz and TBBt and only a slight change in 
the affinity for ATP (Sajnaga et al, 2008). The structural basis for decreased emodin binding 
to human CK2α resulting from a single point mutation (V66A) has been examined by 
molecular dynamics (MD) simulations and energy analysis (Zhang & Zhong, 2010). It was 
found that the V66A mutation resulted in a packing defect due to a change in 
hydrophobicity.  It led to abnormal behavior of the glycine-rich loop, α-helix, and C-loop. 
The critical role of Ile66 in cosubstrate binding and selection, besides forcing the nucleotide 
ligands to adopt different positions in the binding pocket, was also demonstrated in a 
mutational study (Jakobi et al., 1994; Jakobi & Traugh, 1992, 1995). 
Chaillot and collaborators (2000) studied the role of Gly177 in conserved region VII of the 
catalytic domain, which is close to the active site. It was revealed that the CK2α G177K 
mutant exhibited improved catalytic efficiency for acid peptidic substrates, probably by 
establishing interactions with the acidic residues.  
The acidic residue Asp or Glu of the catalytic loop (corresponding to Glu170 in PKA and 
conserved in most Ser/Thr protein kinases) is responsible for the binding of basic residues 
that specify the protein/peptide substrates. In CK2, the residue is replaced by a histidine 
(His160). Such a substitution could explain the acidophilic properties of CK2, in contrast to 
the basophilic properties of PKA and other Ser/Thr kinases. The actual role of the His160 in 
the determination of the site specificity of CK2 was assessed by Dobrowolska and 
collaborators (1994). Interestingly, subsequent mutational studies in which His160 was 
replaced with alanine or aspartic acid ruled out any significant role of this residue in 
substrate recognition (Sarno et al., 1997b). 
A CK2 inactive mutant (D156A) was produced based on structural homology to kinase 
PKA. The mutant protein was able to compete efficiently with the wild-type CK2 for the 
regulatory  subunits. Although it does not exhibit kinase activity, the D156A mutant can 
bind CK2 to form an inactive holoenzyme. Moreover, the mutant abolishes the inhibitory 
effect of CK2 on CK2-mediated phosphorylation of calmodulin. These results suggest that 
CK2 D156A may be a useful dominant-negative mutant for elucidation of the cellular 
functions of the CK2 regulatory subunit (Cosmelli et al., 1997). 
2.1.4 Mutations of CK2α in the glycine-rich loop 
The glycine-rich sequence (G-loop) is one of the most critical structures of protein kinases, 
since it contributes in many ways to enzyme activity. This multifunctional structural 
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element participates in nucleotide binding, substrate recognition,  catalysis, and regulation 
of activity (Bossemeyer et al., 1994). In their extensive mutational studies combined with 
biochemical characterization, Sarno and collaborators (1999) confirmed that some basic 
residues in the glycine-rich loop of the CK2α, particularly Lys49, are implicated in substrate 
recognition and inhibition by polyanions. Another residue located within this region, Gly48, 
is involved in binding the ATP phosphate moiety. Replacement of Gly48 by alanine in CK2α 
affected its catalytic efficiency and specificity. It is thought that alanine causes this 
phenotype by creating an electrostatic barrier between ATP and the peptide substrate 
(Chaillot et al., 2000). 
2.1.5 Mutations of CK2 in the C-terminal region 
The C-terminal region of vertebrate CK2α is composed of 54 amino acids. Knowledge of this 
segment is rather poor, except for phosphorylation by kinase p34Cdc2 and interaction with 
isomerase Pin1 (Bosc et al., 1995; Messenger et al., 2002). It is known from the publications 
on crystallization of CK2 that the catalytic subunits are particularly sensitive to degradation, 
which makes the crystallization process of the entire subunit difficult (Niefind et al., 2000, 
2001). Truncation at the C-terminus reduced the intrinsic degradability of CK2α and 
allowed its crystallization and the determination of its 3D structure. Starting from sequence 
alignments of C-termini from different CK2s, Grasselli and collaborators (2004) 
constructed a mutant carrying the substitution of two distal prolines with alanines 
(P382A/P384A). Most intriguing was the resistance of the mutant to proteolytic 
degradation, which makes this protein an excellent candidate for crystallization of the entire 
CK2 subunit. 
Bischoff and collaborators (2011) have recently determined for the first time the structure of 
the full-length human CK2α`C336S subunit. A point mutation of CK2α` was necessary to 
prevent covalent dimerization from intermolecular disulfide bridges formed by Cys336. 
However, these results shed light on the differences between the two catalytic subunits, α 
and α` (e.g., significantly lower affinity of CKα` towards CK2β relative to that of CK2α). 
2.1.6 Mutagenesis of CK2α in other regions 
Determination of the structure of the CK2 holoenzyme and individual subunits provided 
knowledge about the nature and location of the interface between catalytic and regulatory 
subunits (Niefind et al., 2001). Using structure-guided alanine-scanning mutagenesis 
combined with isothermal titration calorimetry (ITC), energetic “hot spots” were identified 
on the surface of CK2 that determine the / subunit interaction (Raaf et al., 2011). Three 
single and one double CK2 subunit mutants were produced, in which individual 
hydrophobic amino acids located within the CK2 interface were replaced by alanine. The 
ITC analysis of CK2 mutants revealed that substitution of Leu41 and Phe54 were most 
disruptive to binding of CK2. Moreover, the L41A and F54A mutants retained their kinase 
activity, compared to the wild-type CK2. Based on the results mentioned above, it can be 
claimed that these residues are suspected of being interaction “hot spots” (Raaf et al., 2011). 
The amino-acid sequence and the structure of yeast protein kinase CK2α differ from those of 
CK2α’ and other eukaryotic CK2α subunits. CK2α is unique in containing a 38-amino-acid 
loop consisting of two α-helical structures situated close to structures engaged in ATP/GTP 
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and substrate binding (Niefind et al., 2001). Modeling of the tertiary structure of the CK2α 
showed that, after removing both α-helical motifs, the CK2α subunit assumes a structure 
that is more similar to that of CK2α’ than it is to the structure of intact CK2α. The deletion of 
the 38 amino acids from CK2α drastically decreases its catalytic efficiency.  Its characteristics 
are similar to yeast CK2α’ with respect to sensitivity to salt, heparin and spermine (Sajnaga 
et al., 2008) (Fig. 3). 
 
Fig. 3. Conformational consequences of mutagenesis of the yeast CK2α catalytic subunit. 
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CK2 residues Location Mutant Reference/source 
Substrate recognition and inhibition by polyanions 
K49 Subd. I;  Gly loop K49A Sarno et al., 1999 
K74 
K75 
K76 
K77 
Subd. II/III, Lys rich loop 
 
K74-77A,  K77A 
Sarno et al., 1997a, 1998, 
1999, Vaglio et al. 1996 
Gatica et al., 19941 
K79 
R80 
K83 
Subd. III, Helix C 
K79A, 
R80A/K83A 
Sarno et al., 1998, 1999 
K122 Subd.V, Linker region  K122A Sarno et al., 1997a, 1999 
H160 Subd. VIb, Catalytic loop H160D Dobrowolska et al., 1994 
R191  
R195  
K190 
K198 
Subd. VIII, p+1 loop 
R191, 195, K190A 
K198A 
Sarno et al., 1997a, 1998, 
1999; Vaglio et al., 1996 
Catalytic efficiency and specificity 
G482 Subd. I, Gly loop G48D Chaillot et al., 2000 
V66  
M163 
Subd. II 
Subd. VIb 
V66A M163A 
CK2α 1-335 
Yde et al., 2005 
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V66  
I174 
Subd. II 
Subd. VII 
V66A/I174A Sarno et al., 2005 
V66/W176 Subd. II, Subd. VII V66A/W176F 
Jakobi and Traugh, 1992, 
1995 
N118 
Subd. V, ATP/GTP binding 
region 
N118A,  
CK2αΔN118 
Srinivasan et al., 1999;  
Jakob et al., 2000 
D156 Subd. VIb D156A Cosmelli et al., 1997 
M163 Subd. VIb M163G Sarno et al., 2005 
G177 Subd. VII G117K Chaillot et al., 2000 
N189 Subd. VII, Activating segment N189R Srinivasan et al., 1999 
Regulation by β  subunit 
L41 Subd. I L41A Raaf et al., 2011 
L54 Subd. I, ATP/GTP binding region  L54A Raaf et al., 2011 
V66 
W176 
Subd. II 
Subd. VII 
V66A, 
V66A/W176F 
Sarno et al., 1997b 
Jakobi &Traugh, 1992 
Constitutive activity 
M6 –V30 N-terminus 
 Δ2-12, Δ2-18, 
Δ2-24, Δ2-30 
Sarno et al., 2001, 2002; 
Cristiani et al., 2011 
Y125 Subd. V, Hinge region Y125F4 Cristiani et al., 2011 
E180 Subd. VII, Activation segment E180A Sarno et al., 2002 
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E182 Subd. VII, Activation segment Y182F Sarno et al., 2002 
Stability 
M336-Q393 C-terminus Δ336-393 Ermakova et al., 2003 
P382 
P384 
C-terminus 
P382A  
P384A 
Grasselini et al., 2004 
C3363 C-terminus C336S Bischoff et al., 2011 
aThe residue numbers correspond with those of human CK2α, unless otherwise indicated. The Roman 
numerals indicate the eleven conserved subdomains present in the catalytic domain of all protein 
kinases (Hanks & Hunter, 1995). Abbreviations: 1CK2α from Xenopus laevis; 2CK2α from Yarrovia 
lipolytica; 3Human CK2α’; 4in silico mutation. 
Table 1. Summary of CK2α mutantsa 
The deletion of the loop of amino acids 91-128 from yeast CK2α led to behavioral and 
structural similarity to CK2α` (Sajnaga et al., 2008). The 3D models of proteins were created 
using the SWISS-MODEL software based on protein structure templates (PDB code 1ds5D) 
available in the Protein Data Bank and visualized with the PyMOL software. 
Chimeras of different kinases can be easily engineered using recombinant DNA technology 
and used in studies on the structure and function of kinase. To study the effect of CK2β on 
the activity of CK1α, Jedlicki and collaborators (2008) generated CK2α/CK1α chimeras that 
were able to bind tightly to the CK2β regulatory subunit, but maintain the peptide substrate 
specificity of CK1. This is related to the capacity of the CK2β to regulate the activity of 
CK2α, as well as other protein kinases, such as A-Raf, C-Mos, and Chk1. It has been shown 
that a chimera combining a large part of the CK1α kinase with the N-terminal region of 
CK2α that is responsible for binding CK2β can be stimulated by this subunit. It is possible 
that such chimeras could be used to test the presence of “the docking site” on the CK2β 
subunit, which would bring substrate molecules near the catalytic subunits. 
2.2 Mutagenesis of the regulatory subunit CK2β 
From the primary sequence of the β subunit, it is obvious that the charged amino acids are 
not equally distributed. The acidic residues are clustered in the N-terminal half, whereas the 
basic residues are clustered in the C-terminal part of the molecule. Mutational studies have 
shown that, in contrast to cyclins, which invariably act as indispensable activators of CK2-
related CDKs, the CK2β subunit fulfills antagonist functions. The features of CK2β can be 
explored by generating large synthetic fragments, some of which reproduce the C-terminal 
moiety and thus stimulate its catalytic activity. Fragments reproducing segments of the N-
terminal sequence are inhibitory, which becomes especially evident when calmodulin is the 
substrate (Marin et al, 1992, 1995; Meggio et al, 1994; Sarno et al, 1997a). 
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2.2.1 Mutations of CK2β that affect autophosphorylation 
The CK2β subunit is known to be autophosphorylated by the catalytic subunit. 
Autophosphorylation occurs on serine residues at positions 2 and 3 in the amino-terminal 
region of the molecule. Both these serines fit CK2 consensus specificity requirements (Marin 
et al, 1992). This finding was corroborated by the fact that the mutant S2,3G (i.e., S2G/S3G) 
is completely incapable of autophosphorylation (Hinrichs et al, 1993). Deletion of the first 
four amino acids (CK2β Δ1-4), which eliminated autophosphorylation of CK2β, had no 
significant effect on the reconstruction of CK2 holoenzymes nor on their catalytic activity, 
thermostability, and responsiveness to polylysine. Unlike the wild-type CK2β, however, 
CK2β Δ1-4 failed to confer to the reconstituted holoenzyme the typical responsiveness to 
NaCl stimulation. These results indicated that autophosphorylation sites are not required on 
CK2 for conferring a stable structure and full catalytic activity. In contrast an 
autophosphorylation site is implicated in the NaCl-dependent fine-tuning of CK2 activity 
(Meggio et al., 1993). Interestingly, the acidic stretch heavily influences autophosphorylation 
of the β subunit, even though Ser2 is more than 50 amino acids away in the primary 
sequence (Boldyreff et al., 1994). 
2.2.2 Mutations of CK2β that affect binding with CK2α 
In order to shed light on the mechanisms by which the CK2β subunits affect the catalytic 
properties of CK2 and to elucidate the molecular interactions between the catalytic and 
regulatory subunits of CK2, Boldyreff and collaborators (1992, 1993) generated a number of 
mutants of the CK2β subunit, which were tested for their ability to functionally replace the 
wild-type CK2β. These authors showed that deletion of the last 44 residues of the C-end 
(CK2β Δ171-215) eliminated the capacity to form tetramers with CK2α and to stimulate 
activity. However, deletion of the last 34 amino acids (CK2βΔ181-215) yielded an active 
CK2β that had lower affinity for CK2α. Shorter deletions (e.g., CK2β Δ194-215) did not affect 
the interaction between the catalytic and regulatory subunits of CK2. Boldyreff and 
collaborators demonstrated that deletion mutants in which the last 45 or more amino acids 
are missing were not able to assemble with the α subunit. These data identified the C-
terminal segment of CK2β as essential for association with the CK2α subunit, with special 
reference to its 171-180 stretch, which is indispensable both to form tetrameric CK2 and to 
stimulate activity of the CK2 catalytic subunit (Boldyreff et al., 1994). Tight interaction 
between the CK2α and CK2β subunits, accomplished by the C-terminal part of the CK2β 
subunit, was also described (Kusk et al., 1995; Marin et al., 1997). 
Mutagenesis along with crosslinking and peptide studies have shown that the acidic 
amino acid stretch of CK2β from residues 55-64 interacts with a corresponding basic 
stretch of the CK2α subunit. However, these weak electrostatic interactions seem to 
determine the activity of, but not the formation of, the CK2 holoenzyme (Krehan et al., 
1996, Sarno et al, 1997b). 
Kusk and collaborators (1995) used mutagenesis of CK2 subunits with a yeast two-hybrid 
system to explore domains involved in intersubunit contact. [In the yeast two-hybrid 
system, a peptide or protein is fused to part A of a transcriptional activator.  Another 
peptide or protein is fused to part B.  Transcriptional activation of an easily assayed 
reporter gene occurs only when part A and part B come together.  Parts A and B 
 
Genetic Manipulation of DNA and Protein – Examples from Current Research 150 
themselves cannot interact to form the transcriptional activator, nor can either part 
individually (part A, the part A fusions, part B, and the part B fusions) cause the reporter 
to be expressed.  However, if the fusions interact, part A and part B can come together, 
and the reporter is activated.  This is an indication that the peptides or proteins in the 
fusions can interact.] A series of plasmid constructs was prepared. They encoded N-
terminal or C-terminal truncations of the CK2 and CK2 subunits to indicate which 
regions of the subunits were engaged in CK2 holoenzyme formation in yeast cells. The 
data revealed that the regulatory CK2  subunit has a modular structure. An N-terminal 
domain (residues 20-145) is responsible for homodimerization (CK2/CK2). A C-
terminal domain (residues 152-200) is necessary for heterodimerization (CK2/CK2). 
Amino acid residues 1 to 20 in the N-terminus and 351 to 391 in the C-terminus of CK2 
are dispensable for interaction with the regulatory subunit. 
2.2.3 Mutations of CK2β that affect the activity of CK2α 
The modulation of CK2α subunit activity by CK2β has a stimulatory effect on most 
substrates. However, when calmodulin is used as the substrate, the CK2β subunit almost 
completely inhibits the activity of the catalytic subunit (Guerra et al., 1999). This inhibition 
can be overcome by addition of polylysine (Meggio et al, 1992). Mutagenesis studies on the 
CK2β subunit revealed an acidic stretch (amino acids 55-64) that is responsible for the 
inhibitory effect and for the stimulation by polylysine (Meggio et al., 1994). Interestingly, 
mutants of CK2β bearing substitutions at positions 55, 57, and 59-64 to alanine produced up 
to 4-fold more active holoenzyme after assembling with the catalytic α subunit than did the 
wild type. At the same time, these mutants were refractory to the stimulatory effect of 
polylysine. This finding revealed that the acidic N-terminal cluster of CK2β, especially 
Asp55 and Glu57, is involved in intrinsic down-regulation of CK2 basal activity and has 
been implicated in responsiveness to various effectors (Boldyreff et al., 1993, 1994). 
Other data provided by Hinrichs and collaborators (1995) demonstrated that Pro58 located 
in the center of the acidic segment also constitutes an important structural feature affecting 
the function of down-regulation of CK2 towards the catalytic subunits. The effect of a 
mutation of proline to alanine resulted in an effect that was similar to mutation of the acidic 
residues alone. It produced hyperactive CK2 subunits that stimulated the CK2 activity to 
a greater extent than did the wild-type CK2 subunit. 
2.2.4 Mutations of CK2β that affect export of the holoenzyme 
It is known that protein kinase CK2 is present in not only the cytoplasm, nuclei, and several 
other cell organelles, but also on the external side of the cellular membrane (Kubler et al, 
1983). Rodrigez and collaborators (2008) have studied the role of CK2β in the export of the 
holoenzyme to the extracellular membrane through deletion and point mutations. The 
region of CK2β between amino acids 20 and 33 was found to be necessary, but not sufficient, 
to allow the catalytic subunits to function as an ectokinase. An important function of this 
region is fulfilled by Phe21 and Phe22, which anchor the loop of the 20-33 sequence. 
Another key element of this region is constituted by the acidic residues in positions 26-28. 
They are exposed to the medium, free to interact with other proteins (Bolanos-Garcia et al, 
2006). 
 
Site-Directed Mutagenesis in the Research of Protein Kinases - The Case of Protein Kinase CK2 151 
2.2.5 Mutation of CK2β that affects its stability 
Overexpression of CK2 catalytic subunits leads to increased cell proliferation and 
transformation, while overexpression of the regulatory CK2 subunit is associated with 
decreased proliferation in yeast and mammalian cells (Li et al., 1999; Lebrin et al., 2001; Vilk 
et al., 2001). Moreover, CK2β is physiologically expressed at a higher level than CK2α, and 
the excess of the regulatory subunit is rapidly ubiquitinated and degraded in a proteasome- 
dependent manner (Luscher & Litchfield, 1994; Zhang et al., 2002). To protect CKβ from the 
degradation machinery and to stabilize it, six surface-exposed lysine residues were mutated 
to arginine (French et al., 2007). The 6KR mutant functioned as normal CK2β, but it was not 
sensitive to proteasome inhibition. The physiological role of mutagenesis-mediated CK2β 
stabilization was also examined with the use of cell proliferation assays. A significant 
decrease in proliferation was observed in cells expressing the 6KR mutant when compared 
to wild-type CK2β. The authors suggest that the stabilized form of the CK2 regulatory 
subunits can be utilized to inhibit cell proliferation in cancer cells (French et al., 2007). 
2.3 Mutagenesis of CK2 substrates 
Protein kinase CK2 is a multi-substrate enzyme with a large number of cellular partners. In 
2003, Meggio and Pinna updated the list of 307 CK2 substrates with 308 sites 
phosphorylated by CK2 (Meggio & Pinna, 2003). This number is now out-of-date, as novel 
CK2 protein substrates are discovered every year. A bona fide CK2 substrate may possess one 
or several phosphoacceptor sites affected by CK2, but an analysis of the initial amino acid  
sequences of possible CK2 partners may show a dozen or so putative CK2 sites. Site-
directed mutagenesis is a useful tool to create CK2 substrate mutants. Such proteins are 
produced (1) to indicate precisely the phosphorylatable amino acid, (2) to study the 
physiological significance of CK2-mediated phosphorylation of a given protein substrate, or 
(3) to confirm the physiological relevance of CK2-mediated phosphorylation. Presented 
below are several examples of the mutagenesis of CK2 substrates. 
Mdm2 is a cellular oncoprotein that down-regulates the growth suppressor protein p53 
(Barak et al., 1992). Computer analysis of the amino acid sequence of Mdm2 revealed 19 
putative CK2 phosphorylation sites. Three Mdm2 mutants with deletions at codons 1-114, 
93-285, and 271-491 were produced to exclude sites that are not affected by CK2. The 
phoshorylation assays revealed that only the central part of Mdm2 is phosphorylated. Based 
on further detailed analysis of the remaining CK2 consensus sites, Ser269 was chosen to be 
the most promising. Using overlap extension PCR (see section 2.7 in the chapter by 
Sturtevant), the Mdm2 point mutant S269A was constructed and the relevant CK2 
phosphorylation site was finally discovered (Götz et al., 1999). 
In some protein substrates, putative CK2 phosphorylation sites are located close to one 
another, and thus several point mutants had to be produced to score them. The consensus 
sequence analysis of the N-terminal domain of the human transcription factor Tcf-4 
indicated multiple sites that fit the motif for CK2 phosphorylation. No CK2-mediated 
phosphorylation was detected on the Tcf-4 fragments comprising amino acids 1-30 and 1-49. 
Thus, the best candidates for CK2-affected amino acids were the serine residues located in 
the Tcf-4 peptide T54NQDSSSDSEAERRP68. Three Tcf-4 mutants, one triple point mutant 
(S58A/S59A/S60A) and two single point mutants (S58E and S60E) were made to help 
indicate the phosphorylatable amino acid. In vitro phosphorylation assays revealed that all 
three adjacent serines are modified by CK2 with different efficiencies (Miravet et al., 2002). 
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Sic1 is a yeast protein that specifically inhibits Clb/Cdk activity in the G1 phase, so that 
DNA replication is suppressed (Verma et al., 2001; Nash et al., 2001). Moreover, Sic1 
undergoes multistep phosphorylation. Therefore, Sic1 phosphorylation occurs at several 
positions. One looks like the CK2 consensus site. CK2-mediated phosphorylation of Sic1 
within the Q199ESEDEED sequence was confirmed both in vitro and in vivo in Saccharomyces 
cerevisiae cells (Coccetti et al., 2004, 2006). Mutations of the CK2 consensus site on Sic1 
(S201A and S201E) alter the coordination between cell growth and division.  They also 
change the level and time-course of S-Cdk kinase activity. These mutation data strongly 
support the physiological relevance of Sic1 phosphorylation for inhibitory activity (Coccetti 
et al., 2004). 
The regulatory effect of CK2 activity on the Wnt signaling pathway is widely known (Pinna, 
2002; Litchfield, 2003). Kinase phosphorylates and interacts with β-catenin and thus 
enhances the stability and transcriptional activity of β-catenin (Song et al, 2003; Seldin et al, 
2005). The AKT/PKB kinase is also a well-known CK2 substrate and interacting partner. 
CK2-mediated phosphorylation at Ser129 causes AKT hyperactivation (Di Maira et al, 2005; 
Guerra, 2006). CK2 may link the two pathways..  
To elucidate the roles of CK2 in the Wnt and AKT/PKB signaling pathways, the AKT 
phosphorylation-deficient mutant (S129A) was overexpressed in an embryonic cell line. The 
β-catenin-dependent transcriptional activity was analyzed. The data obtained indicate that 
blockage of AKT phosphorylation by CK2 impairs β-catenin activity and decreases its 
stability. Therefore, CK2-mediated AKT phosphorylation at Ser129 is a necessary step in the 
up-regulation of the β-catenin transcriptional activity in human embryonic kidney cells 
(Ponce et al., 2011). 
Besides phosphorylation of numerous cellular proteins, CK2 directly interacts with many of 
them forming protein-protein complexes (Litchfield, 2003). Both catalytic and regulatory 
CK2 subunits can interact with different proteins, independently of the holoenzyme (Bibby 
et al., 2005). Wee1 kinase, involved in cell cycle progression, is one such CK2 protein 
partner. The Wee1 kinase is a key inhibitor of cyclin-dependent kinase (CDK1) and mitotic 
entry in eukaryotes. Several deletion mutants of the Wee1 catalytic domain were produced 
to investigate the interaction with CK2 subunits. Immunoprecipitation experiments revealed 
that Wee1 binds CK2 via two domains of Wee1 (comprising amino acids 59-71 and 232-
332) and two regions of CK2 (comprising residues 1-5 and 155-170). Although the 
interaction does not affect Wee1 activity, it up-regulates CDK1 by reversing the Wee1-
mediated inhibitory effect on CDK1. These findings reinforce the notion that CK2 can serve 
other protein kinases. It may be a universal regulatory subunit that can act independently of 
the CK2 holoenzyme (Olsen et al., 2010). 
3. Conclusion 
Even 58 years after its first description (Burnett & Kennedy, 1954), the story of protein 
kinase CK2 has not been fully clarified. This enzyme catalyzes phosphorylation of over 300 
substrates. They are characterized by having multiple acidic residues surrounding the 
phospho-acceptor amino acid. Consequently, CK2 plays a key role in several physiological 
and pathological processes (Guerra & Issinger, 2008). After all those years of research, we 
are still asking the question: how is it possible that one kinase can be involved in so many 
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different biochemical processes in the cell? Using different biochemical and genetic 
methods, we have solved several problems connected with the structure and mechanism of 
the catalytic action of this enigmatic protein kinase. The application of mutagenesis methods 
in many cases has helped us and will continue to help us get answers to many problems 
connected with CK2 activity. Among them are the following: 
- The interaction between subunits 
- Catalytic specificity and efficiency 
- Substrate recognition 
- Regulation by the β-subunit 
- Stability of the subunits 
- Interactions with modulators and substrates 
- The effect of phosphorylation on catalytic activity 
- Constitutive CK2 activity. 
A protein kinase, such as CK2, is difficult to explore with respect to its physiological 
functions. CK2 has been shown to be involved in numerous aspects of cell proliferation and 
survival, including cell cycle progression and apoptosis control (Ahmad et al., 2008; Ahmed 
et al., 2002; Batistuta, 2009; Gyenis & Litchfield, 2008; Meggio & Pinna, 2003; Litchfield, 
2003). Alterations in the levels or activity of CK2 have been implicated in a variety of human 
diseases, including cancers (Guerra & Issinger, 2008). All these observations raise important 
questions regarding the mechanisms that control CK2 activity and specificity. These 
questions have a special value, since defects in regulation of these processes could 
contribute to tumorigenesis.  
In this context, the application of mutagenesis methods, together with other techniques (e.g., 
molecular modeling), may be very useful in designing highly effective and specific 
inhibitors that are promising for CK2-based target therapy. 
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